Literature DB >> 33860181

EEG Gamma Band Alterations and REM-like Traits Underpin the Acute Effect of the Atypical Psychedelic Ibogaine in the Rat.

Joaquín González1, Matias Cavelli1,2, Santiago Castro-Zaballa1, Alejandra Mondino1,3, Adriano B L Tort4, Nicolás Rubido5,6, Ignacio Carrera7, Pablo Torterolo1.   

Abstract

Ibogaine is a psychedelic alkaloid that has attracted large scientific interest because of its antiaddictive properties in observational studies in humans as well as in animal models. Its subjective effect has been described as intense, vivid dream-like experiences occurring while awake; hence, ibogaine is often referred to as an oneirogenic psychedelic. While this unique dream-like profile has been hypothesized to aid the antiaddictive effects, the electrophysiological signatures of this psychedelic state remain unknown. We previously showed in rats that ibogaine promotes a waking state with abnormal motor behavior along with a decrease in NREM and REM sleep. Here, we performed an in-depth analysis of the intracranial electroencephalogram during "ibogaine wakefulness". We found that ibogaine induces gamma oscillations that, despite having larger power than control levels, are less coherent and less complex. Further analysis revealed that this profile of gamma activity compares to that of natural REM sleep. Thus, our results provide novel biological evidence for the association between the psychedelic state and REM sleep, contributing to the understanding of the brain mechanisms associated with the oneirogenic psychedelic effect of ibogaine.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 33860181      PMCID: PMC8033602          DOI: 10.1021/acsptsci.0c00164

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  55 in total

1.  Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors.

Authors:  R T Layer; P Skolnick; C M Bertha; U K Bandarage; M E Kuehne; P Popik
Journal:  Eur J Pharmacol       Date:  1996-08-08       Impact factor: 4.432

2.  Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.

Authors:  S Helsley; D Fiorella; R A Rabin; J C Winter
Journal:  Pharmacol Biochem Behav       Date:  1998-02       Impact factor: 3.533

3.  Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.

Authors:  Thomas Kingsley Brown; Kenneth Alper
Journal:  Am J Drug Alcohol Abuse       Date:  2017-05-25       Impact factor: 3.829

4.  Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.

Authors:  Carla Pallavicini; Martina G Vilas; Mirta Villarreal; Federico Zamberlan; Suresh Muthukumaraswamy; David Nutt; Robin Carhart-Harris; Enzo Tagliazucchi
Journal:  Neuroimage       Date:  2019-06-24       Impact factor: 6.556

5.  A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats.

Authors:  Paola Rodrı Guez; Jessika Urbanavicius; José Pedro Prieto; Sara Fabius; Ana Laura Reyes; Vaclav Havel; Dalibor Sames; Cecilia Scorza; Ignacio Carrera
Journal:  ACS Chem Neurosci       Date:  2020-05-18       Impact factor: 4.418

6.  Transient Dose-dependent Effects of Ketamine on Neural Oscillatory Activity in Wistar-Kyoto Rats.

Authors:  Joshua D Manduca; Rachel-Karson Thériault; Olivia O F Williams; Duncan J Rasmussen; Melissa L Perreault
Journal:  Neuroscience       Date:  2020-05-15       Impact factor: 3.590

7.  Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats.

Authors:  S I Dworkin; S Gleeson; D Meloni; T R Koves; T J Martin
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

8.  Ketamine: differential neurophysiological dynamics in functional networks in the rat brain.

Authors:  A Ahnaou; H Huysmans; R Biermans; N V Manyakov; W H I M Drinkenburg
Journal:  Transl Psychiatry       Date:  2017-09-19       Impact factor: 6.222

9.  The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.

Authors:  Robin L Carhart-Harris; Robert Leech; Peter J Hellyer; Murray Shanahan; Amanda Feilding; Enzo Tagliazucchi; Dante R Chialvo; David Nutt
Journal:  Front Hum Neurosci       Date:  2014-02-03       Impact factor: 3.169

10.  EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis.

Authors:  Santiago Castro-Zaballa; Matías Lorenzo Cavelli; Joaquin Gonzalez; Antonio Egidio Nardi; Sergio Machado; Cecilia Scorza; Pablo Torterolo
Journal:  Front Psychiatry       Date:  2019-01-17       Impact factor: 4.157

View more
  3 in total

Review 1.  Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.

Authors:  Rebecca Smausz; Joanna Neill; John Gigg
Journal:  J Psychopharmacol       Date:  2022-05-30       Impact factor: 4.562

2.  Ketamine and sleep modulate neural complexity dynamics in cats.

Authors:  Claudia Pascovich; Santiago Castro-Zaballa; Pedro A M Mediano; Daniel Bor; Andrés Canales-Johnson; Pablo Torterolo; Tristan A Bekinschtein
Journal:  Eur J Neurosci       Date:  2022-03-19       Impact factor: 3.698

3.  Efficient Access to the Iboga Skeleton: Optimized Procedure to Obtain Voacangine from Voacanga africana Root Bark.

Authors:  Bruno González; Catherine Fagúndez; Alejandro Peixoto de Abreu Lima; Leopoldo Suescun; Diver Sellanes; Gustavo A Seoane; Ignacio Carrera
Journal:  ACS Omega       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.